Acadia Pharmaceuticals Statistics
Total Valuation
ACAD has a market cap or net worth of $3.24 billion. The enterprise value is $2.34 billion.
| Market Cap | 3.24B |
| Enterprise Value | 2.34B |
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ACAD has 172.83 million shares outstanding. The number of shares has increased by 2.82% in one year.
| Current Share Class | 172.83M |
| Shares Outstanding | 172.83M |
| Shares Change (YoY) | +2.82% |
| Shares Change (QoQ) | +1.51% |
| Owned by Insiders (%) | 0.29% |
| Owned by Institutions (%) | 74.32% |
| Float | 129.32M |
Valuation Ratios
The trailing PE ratio is 8.96 and the forward PE ratio is 18.44.
| PE Ratio | 8.96 |
| Forward PE | 18.44 |
| PS Ratio | 2.70 |
| Forward PS | 2.22 |
| PB Ratio | 2.34 |
| P/TBV Ratio | 2.59 |
| P/FCF Ratio | 39.52 |
| P/OCF Ratio | 33.22 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 17.30, with an EV/FCF ratio of 28.49.
| EV / Earnings | 6.45 |
| EV / Sales | 1.94 |
| EV / EBITDA | 17.30 |
| EV / EBIT | 19.10 |
| EV / FCF | 28.49 |
Financial Position
The company has a current ratio of 3.82, with a Debt / Equity ratio of 0.05.
| Current Ratio | 3.82 |
| Quick Ratio | 3.48 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.48 |
| Debt / FCF | 0.88 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 31.43% and return on invested capital (ROIC) is 26.98%.
| Return on Equity (ROE) | 31.43% |
| Return on Assets (ROA) | 4.89% |
| Return on Invested Capital (ROIC) | 26.98% |
| Return on Capital Employed (ROCE) | 8.37% |
| Weighted Average Cost of Capital (WACC) | 8.92% |
| Revenue Per Employee | $1.51M |
| Profits Per Employee | $453,921 |
| Employee Count | 798 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 12.49 |
Taxes
| Income Tax | -205.02M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -22.30% in the last 52 weeks. The beta is 0.89, so ACAD's price volatility has been lower than the market average.
| Beta (5Y) | 0.89 |
| 52-Week Price Change | -22.30% |
| 50-Day Moving Average | 21.79 |
| 200-Day Moving Average | 23.34 |
| Relative Strength Index (RSI) | 42.04 |
| Average Volume (20 Days) | 2,707,027 |
Short Selling Information
The latest short interest is 8.32 million, so 4.81% of the outstanding shares have been sold short.
| Short Interest | 8.32M |
| Short Previous Month | 9.09M |
| Short % of Shares Out | 4.81% |
| Short % of Float | 6.43% |
| Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, ACAD had revenue of $1.20 billion and earned $362.23 million in profits. Earnings per share was $2.09.
| Revenue | 1.20B |
| Gross Profit | 768.42M |
| Operating Income | 122.33M |
| Pretax Income | 157.21M |
| Net Income | 362.23M |
| EBITDA | 135.06M |
| EBIT | 122.33M |
| Earnings Per Share (EPS) | $2.09 |
Balance Sheet
The company has $976.45 million in cash and $71.85 million in debt, with a net cash position of $904.59 million or $5.23 per share.
| Cash & Cash Equivalents | 976.45M |
| Total Debt | 71.85M |
| Net Cash | 904.59M |
| Net Cash Per Share | $5.23 |
| Equity (Book Value) | 1.39B |
| Book Value Per Share | 8.03 |
| Working Capital | 936.21M |
Cash Flow
In the last 12 months, operating cash flow was $97.53 million and capital expenditures -$15.55 million, giving a free cash flow of $81.99 million.
| Operating Cash Flow | 97.53M |
| Capital Expenditures | -15.55M |
| Depreciation & Amortization | 12.73M |
| Net Borrowing | n/a |
| Free Cash Flow | 81.99M |
| FCF Per Share | $0.47 |
Margins
Gross margin is 63.91%, with operating and profit margins of 10.17% and 30.13%.
| Gross Margin | 63.91% |
| Operating Margin | 10.17% |
| Pretax Margin | 13.08% |
| Profit Margin | 30.13% |
| EBITDA Margin | 11.23% |
| EBIT Margin | 10.17% |
| FCF Margin | 6.82% |
Dividends & Yields
ACAD does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.82% |
| Shareholder Yield | n/a |
| Earnings Yield | 11.16% |
| FCF Yield | 2.53% |
Analyst Forecast
The average price target for ACAD is $30.32, which is 61.71% higher than the current price. The consensus rating is "Buy".
| Price Target | $30.32 |
| Price Target Difference | 61.71% |
| Analyst Consensus | Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (3Y) | 14.69% |
| EPS Growth Forecast (3Y) | 28.42% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ACAD has an Altman Z-Score of 6.26 and a Piotroski F-Score of 5.
| Altman Z-Score | 6.26 |
| Piotroski F-Score | 5 |